April 2018

Johanna Mielke, an IDEAS early stage researcher based at Novartis

Biosimilars: new insights into the regulatory approval process in Europe

April 10, 2018, by Johanna Mielke & Byron Jones

ESR Johanna’s latest publication gives insights into the clinical development strategies used to obtain approval for proposed biosimilars and how these have been assessed by the European Medicines Agency.

EU Funding
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 633567.
©2015 Lancaster University